Quest Diagnostics Incorporated (LON:0KSX)
London · Delayed Price · Currency is GBP · Price in USD 180.60
-0.52 (-0.29%)
At close: Sep 16, 2025
Quest Diagnostics Market Cap
Quest Diagnostics has a market cap or net worth of 14.76 billion as of September 17, 2025. Its market cap has increased by 11.72% in one year.
Market Cap
14.76B
Enterprise Value
19.29B
Revenue
7.68B
Ranking
n/a
PE Ratio
21.40
Stock Price
180.60
Market Cap Chart
Since December 17, 1996, Quest Diagnostics's market cap has increased from 240.44M to 14.76B, an increase of 6,039.69%. That is a compound annual growth rate of 15.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 14.76B | 9.76% |
| Dec 31, 2024 | 13.45B | 10.51% |
| Dec 29, 2023 | 12.17B | -17.69% |
| Dec 30, 2022 | 14.79B | -5.66% |
| Dec 31, 2021 | 15.67B | 33.25% |
| Dec 31, 2020 | 11.76B | 8.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.89B |
| GSK plc | 59.54B |
| Haleon | 32.39B |
| Smith & Nephew | 12.02B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 3.61B |
| HUTCHMED (China) | 2.23B |
| Genus | 1.65B |